The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Table 4

Results of urological examinations and serum PSA levels at baseline and 12 weeks.

	Seoritae extract; (mean ± SD)	Placebo; (mean ± SD)	Between groups; value
, mL/s
Baseline	13.3 ± 5.9	14.5 ± 4.8	0.410
12 weeks	14.3 ± 6.2	16.3 ± 7.1	0.232
Difference	1.01 ± 4.7	1.9 ± 6.4	0.693
PVR, mL
Baseline	32.2 ± 29.3	45.7 ± 49.7	0.484
12 weeks	43.9 ± 57.6	34.2 ± 47.7	0.457
Difference	11.8 ± 52.9	−11.5 ± 48.4	0.142
PSA, ng/mL
Baseline	1.7 ± 1.4	1.4 ± 1.3	0.065
12 weeks	1.9 ± 1.8	1.3 ± 1.3	0.012
Difference	0.2 ± 0.5	−0.1 ± 0.5	0.186

= maximum flow rate; PVR = postvoid residual.